Skip to content
ONTARIO SECURITIES COMMISSION APPROVES AVICANNA’S APPLICATION FOR MANAGEMENT CEASE TRADE ORDER
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Education
Avicenna Academy
MyMedi.ca
Contact
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Education
Avicenna Academy
MyMedi.ca
Contact
Instagram
Twitter
Linkedin
Linkedin
Twitter
Instagram
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Education
Avicenna Academy
MyMedi.ca
Contact
×
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Pharmaceutical Pipeline
Aureus Santa Marta
Education
Avicenna Academy
MyMedi.ca
Contact
News & Press
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
7 April 2025
Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
31 March 2025
Avicanna To Hold Full Year 2024 Earnings Conference Call
17 March 2025
Avicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin Pharma
16 January 2025
Avicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical Company
2 December 2024
Avicanna Reports Q3 2024
14 November 2024
« Prev
1
2
3
4
5
6
7
Next »